Cargando…
Costs and frequency of “off-label” use of INFUSE for spinal fusions at one institution in 2010
BACKGROUND: INFUSE, bone morphogenetic protein-2 combined with bovine Type I collagen in the lumbar tapered fusion device (LT Cage), is used to promote anterior lumbar interbody fusion (ALIF). In spinal surgery, INFUSE is only Federal Drug Administration (FDA) approved for this “on-label” use. While...
Autores principales: | Epstein, Nancy E., Schwall, Garry S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162796/ https://www.ncbi.nlm.nih.gov/pubmed/21886888 http://dx.doi.org/10.4103/2152-7806.83929 |
Ejemplares similares
-
The incidence and cost of devices explanted during single-level anterior diskectomy/fusions
por: Epstein, Nancy E., et al.
Publicado: (2011) -
Pros, cons, and costs of INFUSE in spinal surgery
por: Epstein, Nancy E.
Publicado: (2011) -
Azithromycin/hydroxychloroquine/propofol: Off-label use and propofol infusion syndrome: case report
Publicado: (2020) -
A review of interspinous fusion devices: High complication, reoperation rates, and costs with poor outcomes
por: Epstein, Nancy E.
Publicado: (2012) -
Efficacy and outcomes of dynamic-plated single-level anterior diskectomy/fusion with additional analysis of comparative costs
por: Epstein, Nancy E.
Publicado: (2011)